Kolexia
Gagnaire Champiot Alice Gastro-entérologie
Gagnaire Champiot Alice
Gastro-entérologie
Hôpital François Mitterrand
Dijon, France
46 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Métastase tumorale Adénocarcinome Tumeurs du foie Tumeurs du côlon Entéropathie exsudative Tumeurs du pancréas Carcinomes Cellules tumorales circulantes

Collaborateurs

Voir plus
Drouillard Antoine
Drouillard Antoine
CHU Dijon-Bourgogne, Dijon, France
Bazin Camille
Bazin Camille
Hôpital François Mitterrand, Dijon, France
Minello-Franza Anne
Minello-Franza Anne
Hôpital François Mitterrand, Dijon, France
Lepage Come
Lepage Come
Hôpital François Mitterrand, Dijon, France

Industries

Voir plus
Ipsen
3 collaboration(s)
Dernière en 2021
Amgen
3 collaboration(s)
Dernière en 2022
Olympus
2 collaboration(s)
Dernière en 2022
AstraZeneca
2 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Performance of a blood-based RNA signature for gemcitabine-based treatment in metastatic pancreatic adenocarcinoma.
Journal of gastrointestinal oncology   10 avril 2023
FFCD 1709-SIRTCI phase II trial: Selective internal radiation therapy plus Xelox, Bevacizumab and Atezolizumab in liver-dominant metastatic colorectal cancer.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   21 mai 2022
Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab: Phase II, Multicentric Randomized Trial, Evaluating the Efficacy of Fluoropyrimidine-based Standard Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab
Essai Clinique (Unicancer)   07 janvier 2022
Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic Metastases: Phase II Multicentric Randomized Trial, Evaluating the Best Protocol of Chemotherapy, Associated With Targeted Therapy According to the Tumor KRAS Status, in Metastatic Colorectal Cancer (CCRM) Patients With Initially Non-resectable Hepatic Metastases
Essai Clinique (Unicancer)   14 juin 2021
Identification of resources and skills developed by partners of patients with advanced colon cancer: a qualitative study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer   05 juin 2018
Waldmann's disease: a rare cause of protein losing enteropathy in an adult patient.
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva   14 mars 2018
Randomised controlled trial of lipiodol transarterial chemoembolisation with or without amiodarone for unresectable hepatocellular carcinoma.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   28 juillet 2011
{{person.lastact8.name}}
{{person.lastact8.jour}}   {{person.lastact8.date}}
{{person.lastact9.name}}
{{person.lastact9.jour}}   {{person.lastact9.date}}
{{person.lastact10.name}}
{{person.lastact10.jour}}   {{person.lastact10.date}}